Treatment Indications: 3D‑facial contouring and structural reshaping in high‑projection zones (chin, jawline, cheekbones, nasal dorsum);, restoration of lost facial architecture and sharp angular definition; correction of severe contour deformities, asymmetry, and age‑related volume displacement;, non‑surgical rhinoplasty and chin augmentation;, redefinition of the lower third of the face with high shape retention; correction of deep depressions and structural hollows requiring dense, stable support
Release form: 1 × 1.0 mL pre‑filled sterile glass syringe
Compound: cross‑linked hyaluronic acid (non‑animal origin, manufactured via HICE technology for uniform particle size and reduced BDDE);lidocaine 0.3 %; phosphate‑buffered saline solution (pH ~7.0)
Concentration of GC: 20 mg/mL
Lidocaine: 0.3 %
Indications: volumizing and deep structural contouring in supraperiosteal and deep subcutaneous layers requiring maximum G’ (elastic modulus) and projection;, restoration of severe volume deficits with long‑term shape stability;, correction of deep folds, depressions, and scars with high resistance to muscle movement and minimal migration; providing pronounced lifting and architectural support;, expected effect duration ~12–18 months
Order via WhatsApp
fillme-sale@ya.ru